Timeline

MSH began supporting family planning management with a first long-term project in South Korea, funded by USAID.

MSH began work in Afghanistan to strengthen family planning and rural health services, a relationship that endures nearly 50 years later.

MSH publishes Managing Drug Supply, a seminal handbook documenting practical actions to help countries manage medicine supply systems.

MSH is approaching a 40-year relationship working with Haiti working on rural health and helping provide access to primary health care services to nearly 50% of the population.

MSH commences a groundbreaking commitment to leadership, management, and governance, assisting leaders and managers to develop skills in all areas of health systems.

MSH publishes the International Drug Price Indicator Guide (later known as The International Medical Products Price Guide)—an essential reference for the procurement of pharmaceuticals.

MSH starts working with Bangladesh to improve family planning by training staff and leaders to manage local programs and serves 4.5 million people.

MSH enters into a 15-year relationship with the Philippines to improve family planning and child health services, develop a national health information system, and enroll low-income families in health insurance.

As a strategy for promoting improved pharmaceutical use, MSH establishes the International Network for Rational Use of Drugs (INRUD) to improve medicines management.

MSH begins managing the worldwide Basic Support for Institutionalizing Child Survival (BASICS) project, established by the Partnership for Child Health.

MSH begins work in post-apartheid South Africa to establish equitable, accessible primary health care services, including the prevention and treatment of HIV and AIDS.

MSH starts work in Malawi to reduce child mortality and extend community-based care for HIV and AIDS, TB, malaria, and family planning.

In Rwanda, MSH launches performance-based financing programs for health services, dramatically increasing HIV testing, assisted births, and contraceptive use.

MSH publishes Managers Who Lead: A Handbook for Improving Health Services, its seminal publication providing practical strategies and tools for health care managers.

One day after the devastating earthquake in Haiti, MSH resumes regular delivery of antiretroviral drugs to AIDS patients and distributes more than 1 million family planning commodities in the month after the disaster.

With Ethiopia, MSH completes Africa’s largest national expansion of HIV and AIDS services, reaching 33 million people by shifting health tasks from physicians to community providers.

MSH supports Malawi to implement an ambitious and pioneering “test-and-treat” HIV strategy for pregnant and breastfeeding women, known as Option B+.

MSH publishes the third edition of MDS-3: Managing Access to Medicines and Health Technologies, the world’s leading reference on managing essential medicines in developing countries.

Private-sector drug sellers, also known as accredited drug dispensing outlets, have been scaled up in Tanzania, after expansion to Liberia, Uganda, and Bangladesh. Accredited outlets now serve tens of millions of people.

The FCI Program of MSH is launched, building on three decades of constructive activism, partnership, and capacity building by Family Care International, a leading global voice for women’s health and rights.

To respond to the high cost and low quality of medicines in Kenya, MSH launches MedSource, a private group purchasing organization. MedSource now facilitates the procurement of more than 1,000 health care products.

MSH, Harvard University, Georgetown University, and the Stone Foundation assemble leading voices in global health security to discuss the state of the world’s readiness to fight the next epidemic.

The Bureau for Global Health ranks the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program as 1 of the top 5 most useful USAID projects—out of a field of more than 150 projects.

MSH continues a 40-year tradition of global excellence and innovation in pharmaceutical systems as it launches a new five-year global project, the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program.

Building on a history of improving the health of women and children in Nigeria, MSH launches the President’s Malaria Initiative for States (PMI-S) Project.

Through the Accessible Continuum of Care and Essential Services (ACCESS) Activity, MSH continues to support the Government of Madagascar to accelerate health improvements for 16 million people.

MSH is selected by the Joint Learning Network for Universal Health Coverage (JLN) Steering Group to serve as Network Manager under an agreement with the Bill & Melinda Gates Foundation.

MSH begins hosting the Secretariat for the Civil Society Engagement Mechanism (CSEM) for UHC2030. CSEM endeavors to elevate civil society’s influence to ensure that UHC policies and programs are inclusive and equitable.

USAID awards a major global program, Health Systems for Tuberculosis (HS4TB), to MSH and partners. HS4TB will continue supporting 23 countries’ efforts to strengthen health financing and governance of TB programs.

MSH continues to support the COVID-19 response in the countries where we work by assisting them with infection prevention and control, risk communication and community engagement, commodity and supply chain management, and surveillance and information systems.